CardioSignal non

Feb 4, 2024

CardioSignal, a Finland-based health tech company specializing in the development of a unique, non-invasive atrial fibrillation detection technology, raised $10M in Series A funding. The funds will be used to accelerate the company's international growth and further develop it...

Great! Next, complete checkout for full access to Agetech News.
Welcome back! You've successfully signed in.
You've successfully subscribed to Agetech News.
Success! Your account is fully activated, you now have access to all content.
Success! Your billing info has been updated.
Your billing was not updated.